Sector rally lifts Globus Medical stock Globus Medical (GMED) climbed 5.3% in the latest session, moving alongside a broad advance across medical device stocks as institutional investors appeared to ...

Globus Medical’s second quarter sales for 2025 reached $745.3 million, a year-over-year increase of 18.4%, led largely by its U.S. spine business. The company, which is a top player in the ...

The Globus family of brands has launched a new portal and education platform for travel advisors, along with a B2B ad campaign that highlights the importance of advisors to Globus' business. The ...

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2026 after the market close on Thursday, ...

Globus introduced Globus Choice Excursions, which enable travelers to customize their tour options on 80% of the company’s itineraries throughout Europe and North America. “Globus Choice Excursions ...

Globus Medical is rated Hold, as growth is increasingly reliant on M&A and organic momentum remains muted. GMED's FY26 guidance implies 9% revenue growth, a sharp deceleration from FY25's 16.5%, with ...

As of Tuesday, July 21, Globus Maritime Limited’s GLBS share price has surged by 10.07%, which has investors questioning if this is right time to sell.